Multicenter Study of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Publications

Similar documents
CURRICULUM VITAE. (713) (O) B.S. in Biology, Fu-Jen Catholic University, Taiwan, R.O.C., 1974

De.3 If included in a composite, please identify the composite measure (title and NQF number if endorsed): N/A

Screening Examination of Premature Infants for Retinopathy of Prematurity

Downloaded from journal.gums.ac.ir at 15:41 IRST on Friday February 22nd 2019

INFANTS WITH birth weights less

CURRICULUM VITAE ROBERT JACKSON HARDY. Date of Birth: October 27, 1940 Place of Birth: Alexandria, Louisiana

Evaluating the Cryotherapy for Retinopathy of Prematurity Study (CRYO-ROP) (REPRINTED) ARCH OPHTHALMOL / VOL 125 (NO.

TELLER ACUITY CARDS UPDATE 8/04 NAME: ADDRESS: ADDRESS: CITY: STATE: ZIP CODE: TELEPHONE:

Pulsed mode versus near-continuous mode delivery of diode laser photocoagulation for high-risk retinopathy of prematurity

FINAL RESULTS OF THE EARLY TREATMENT FOR RETINOPATHY OF PREMATURITY (ETROP) RANDOMIZED TRIAL

ALTHOUGH EARLY TREATment

Argon laser photocoagulation for retinopathy of prematurity: long-term outcome

Non-ophthalmologist screening for retinopathy of prematurity

Criteria for the timing of the initial retinal examination to screen for retinopathy of prematurity

Classification of ROP

Retinopathy of Prematurity. Objectives. Normal Retina Development. ROP Pathogenesis 6/8/2018. Thomas W. Hejkal, MD, PhD Eye Consultants, PC

R etinopathy of prematurity (ROP), a condition confined

Laser Therapy Versus Anti-VEGF Agents for Treatment of Retinopathy of Prematurity. Ilya Leskov, MD, PhD Shizuo Mukai, MD

Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser

10. ADVANCED RETINOPATHY OF PREMATURITY

Retinopathy of prematurity (ROP) is a disorder of retinal

Study of Incidence, Clinical Staging and Risk Factors of Retinopathy of Prematurity in Rural Area

Screening Examination of Premature Infants for Retinopathy of Prematurity

Screening for retinopathy of prematurity at Cipto Mangunkusumo Hospital, Jakarta, Indonesia a preliminary report

Retinopathy of prematurity: clinical aspects

Color Vision Measured With Pseudoisochromatic Plates at Five-and-a-Half Years in Eyes of Children From the CRYO-ROP Study

RETINOPATHY OF PREMATUrity

Distribution of Retinopathy of Prematurity and Its Risk Factors

Original Article Refractive status and optical components in premature babies with and without retinopathy of prematurity at 5 years old

Archive of SID. Downloaded from jmums.mazums.ac.ir at 2: on Monday October 8th

Treatment of retinopathy of prematurity

Comparison of Recognition and Grating Acuities in * Very-Low-Birth-Weight Children With and Without,, Retinal Residua of Retinopathy of Prematurity

Clinical Study Macular Development in Aggressive Posterior Retinopathy of Prematurity

EarlyTreatment ROP Study: How It Affects My Practice

Childhood blindness due to ROP

Interobserver Reliability of the Teller Acuity Card Procedure in Pediatric Patients

Prematurity, the Eye and Vision

Late-onset Retinal Detachment Associated with Regressed Retinopathy of Prematurity

CLINICAL SCIENCES. Cost-Utility Analysis of Telemedicine and Ophthalmoscopy for Retinopathy of Prematurity Management

Original Article Refractive status and optical components of premature babies with or without retinopathy of prematurity at 3-4 years old

The Effect of Anemia on Retinopathy of Prematurity in Extremely Low Birth Weight Infants 1

Diode Laser Photocoagulation for Retinopathy of Prematurity: Outcomes After 7 Years of Treatment

OUTCOMES AFTER LASER VERSUS COMBINED LASER AND BEVACIZUMAB TREATMENT FOR TYPE 1 RETINOPATHY OF PREMATURITY IN ZONE I

Grand Rounds. Jenny Temnogorod SUNY Downstate Medical Center Department of Ophthalmology September 19, 2013

MEDICAL POLICY SUBJECT: OCULAR PHOTOSCREENING. POLICY NUMBER: CATEGORY: Technology Assessment

RETINOPATHY OF PREMATURITY: LATE COMPLICATIONS IN THE BABY BOOMER GENERATION ( )

PCMCH ROP Screening Guidelines

Structural outcomes of eyes with threshold retinopathy of prematurity treated with laser therapy or cryotherapy

The New England Journal of Medicine LACK OF EFFICACY OF LIGHT REDUCTION IN PREVENTING RETINOPATHY OF PREMATURITY

OFF-LABEL USE OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR SALVAGE TREATMENT IN PROGRESSIVE THRESHOLD RETINOPATHY OF PREMATURITY

The prevalence of anisometropia aniso-astigmatism and amblyopia in neurofibromatosis type 1

Visual Impairment & Eye Health in Children. Susan Cotter, OD, MS So CA College of Optometry Marshall B Ketchum University Fullerton, CA

Surgical Results and Visual Outcomes of Vitreous Surgery for Advanced Stages of Retinopathy of Prematurity

Outcome of the Treatment of Retinopathy of Prematurity in Qatar

REFRACTIVE OUTCOMES OF THREE-PORT LENS-SPARING VITRECTOMY FOR RETINOPATHY OF PREMATURITY (AN AOS THESIS)

Long term follow up of premature infants: detection of strabismus, amblyopia, and refractive errors

Amblyopia Management Past, Present and Future. Rachel Clarke Specialist Orthoptist, Manchester Royal Eye Hospital

Universal Newborn Eye Screening

Retinopathy of Prematurity: A Visually Impairing Disorder Name English 12 Section 35 Professor Marchbanks September 29, 2005

Quantification of Retinopathy of Prematurity via Vessel Segmentation

NIH Public Access Author Manuscript J AAPOS. Author manuscript; available in PMC 2006 April 25.

A Systematic Review of Vision Screening Tests for the Detection of Amblyopia

LONG-TERM VISUAL OUTCOMES IN EXTREMELY LOW-BIRTH-WEIGHT CHILDREN (AN AMERICAN OPHTHALMOLOGICAL SOCIETY THESIS)

A bs tr ac t. n engl j med 364;7 nejm.org february 17,

Jiao Lyu 1, Qi Zhang 1, Chunli Chen 2,YuXu 1, Xunda Ji 1 and Peiquan Zhao 1*

A lthough many studies of children born preterm have

Diabetes Care 24: , 2001

WMRF Grant Final Report: Vision and visual processing in children who experienced neonatal hypoglycaemia

Cup-to-disc and arteriole-to-venule ratios in preterm birth

Blood Gases And Retinopathy Of Prematurity: The Extremely Low Gestational Age Newborn Study

The Effects of Hydrophilic Contact Lens Wear on the Reduction of Progressive Myopia in Adolescents. by Bob Deck

Antivascular endothelial growth factor for retinopathy of prematurity Helen A. Mintz-Hittner a and Leah M. Best b

Reena Patel, OD, FAAO

Research Article Association of Birth Parameters with Refractive Status in a Sample of Caucasian Children Aged 4 17 Years

Paediatric Ophthalmology Assessment. Justin Mora 2017

4/28/2014. Reena Patel, OD, FAAO. 5 to 10% of all preschool-aged children. Myopia. Hyperopia. Astigmatism. High refractive error

A spectral-domain OCT study of formerly premature children. Prat Itharat MD May 30, 2008 Vanderbilt Eye Institute Preceptor: Dr.

ANTIANGIOGENIC THERAPY WITH INTRAVITREAL BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY

Long-Term Visual Outcome in Proliferative Diabetic Retinopathy Patients After Panretinal Photocoagulation

optic disc neovascularisation

Cumulative illness severity and progression from moderate to severe retinopathy of prematurity

Dordi Austeng, Department of Neuroscience, Box 593, Uppsala University, SE Uppsala, Sweden

Difficult Coding Cases. Ophthalmology. in Pediatric. Kimberly Curnyn, MD Rhonda Buckholtz, CPC, CPCI, CPMA, CDEO, CRC, CHPSE, COPC, CENTC, CGSC

Department of Ophthalmology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

Ultrasonographic Findings in Eyes with Retinopathy of Prematurity in Malaysia

Pseudostrabismus, masking manifest strabismus Mladenov O. 1, Dimitrova G. 1

The management of amblyopia in children: the results of a national survey of orthoptists

CLINICAL TRIALS. SECTION EDITOR: ANNE S. LINDBLAD, PhD. Grating Visual Acuity Results in the Early Treatment for Retinopathy of Prematurity Study

Prevention of retinopathy of prematurity in preterm infants through changes in clinical practice and SpO 2 technology

Early retinopathy of prematurity findings identified with fluorescein angiography

Reviews in Clinical Medicine

Scott R. Lambert, M.D. Marla J. Shainberg, C.O. ABSTRACT INTRODUCTION

Early Human Development

Acute Retinal Necrosis Secondary to Varicella Zoster Virus in an Immunosuppressed Post-Kidney Transplant Patient

Original Research Article. Aparajita Chaudhary 1,*, Dharamveer Sharma 2, Namrata Patel 3, Praveen Kumar 4

Factors Influencing the Prevalence of Amblyopia in Children with Anisometropia

CLINICAL SCIENCES. Rajeev H. Muni, MD, FRCSC; Radha P. Kohly, MD, FRCSC, PhD; Alexander C. Charonis, MD; Thomas C. Lee, MD

Transcription:

Multicenter Study of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Publications Bartholomew PA, Chao J, Evans JL, Hammel AM, Trueb AL, Verness JL, Dobson V, Quinn GE. Acceptance/Use of the Teller acuity card procedure in the clinic. Am Orthoptic J 1996;46:99-105. Bremer L, Fellows RR, Palmer EA, Baker JD, Hardy RJ, Tung B, Rogers GL. Strabismus in premature infants in the first year of life. Arch Ophthalmol 1998; 116:329-333 Cohen KW, Byrne SM. The role of the nurse in assisting with eye examinations on premature infants. Neonatal Network 1989;8:31-35. cryotherapy for retinopathy of prematurity: Natural history ROP: Ocular outcome at 5 1/2 years in premature infants with birth weights less than 1251g. Arch Ophthalmol 2002;120:595-599. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Contrast sensitivity in eyes with threshold ROP from the CRYO-ROP trial. Arch Ophthalmol 2001;119:1129-1133. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Effect of ablative cryotherapy for threshold retinopathy of prematurity: results of Goldmann perimetry at age 10 years. Arch Ophthalmol 2001;119:1120-1125. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmological outcomes at 10 years. Arch Ophthalmol 2001;119:1110-1118. Cryotherapy for Retinopathy of Prematurity Cooperative Group: Multicenter trial of cryotherapy for retinopathy of prematurity: Snellen acuity and structural outcome at 5½ years. Arch Ophthalmol 1996;114:417-424. Cryotherapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of premature birth and retinopathy: status at one year. Arch Ophthalmol 1994;112:903-912. cryotherapy for retinopathy of prematurity: 3½-year outcome--structure and function. Arch Ophthalmol 1993;111:339-344. cryotherapy for retinopathy of prematurity: three-month outcome. Arch Ophthalmol 1990;108:195-204.

cryotherapy for retinopathy of prematurity: one-year outcome--structure and function. Arch Ophthalmol 1990;108:1408-1416. cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988;106:471-479. cryotherapy for retinopathy of prematurity: preliminary results. Pediatrics 1988;81:697-706. Dobson V, Quinn GE, Siatkowski RM, Baker JD, Hardy RJ, Reynolds JD, Trese MT, Tung B, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Agreement between grating acuity at age 1 year and Snellen acuity at age 5.5 years in the preterm child. Invest Ophthalmol Vis Sci 1999;40:496-503 Dobson V, Quinn GE, Abramov I, Hardy RJ, Tung B, Siatkowski RM, Phelps DL, for the Cryotherapy for Retinopathy of Prematurity Group. Color vision measured with standard pseudoisochromatic plates at 5½ years in eyes of children from the CRYO-ROP study. Inv Ophthalmol Vis Sci 1996;37:2467-2474. Dobson V, Quinn GE, Tung B, Palmer EA, Reynolds JD, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Comparison of recognition and grating acuities in very low birth weight children with and without retinal residua of retinopathy of prematurity (ROP). Invest Ophthalmol Vis Sci 1995;36:692-702. Dobson V, Quinn GE, Saunders RA, Spencer R, Davis BR, Risser J, Palmer EA, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Grating visual acuity in eyes with retinal residua of retinopathy of prematurity (ROP). Arch Ophthalmol 1995;113:1172-1177. Dobson V, Quinn GE, Summers CG, Saunders RA, Phelps DL, Tung B, Palmer EA. Effect of acute-phase retinopathy of prematurity on grating acuity development in the very low birth weight infant. Invest Ophthalmol Vis Sci 1994;35:4236-4244. Dobson V, Quinn GE, Biglan AW, Tung B, Flynn JT, Palmer EA. Acuity card assessment of visual function in the cryotherapy for retinopathy of prematurity trial. Invest Ophthalmol Vis Sci 1990;31:1702-1708. Evans MS, Wallace PR, Palmer EA. Fundus photography in infants. J Ophthal Photography 1993;15:38-9.

Gilbert WS, Quinn GE, Dobson V, Reynolds J, Hardy RJ, Palmer EA, for the CRYO- ROP Cooperative Group. Partial retinal detachment at 3 months after threshold retinopathy of prematurity: Long term structural and functional outcome. Arch Ophthalmol 1996;114:1085-1091. Gilbert WS, Dobson V, Quinn GE, Reynolds J, Tung B, Flynn JT. The correlation of visual function with posterior retinal structure in severe retinopathy of prematurity. Arch Ophthalmol 1992;110:625-631. Hardy RH, Palmer EA, Dobson D, Summers CG, Phelps DL, Quinn GE, Good WV, Tung B, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Risk analysis of Prethreshold Retinopathy of Prematurity. Arch Ophthalmol 2003;121:1697-1701. Hardy RJ, Palmer EA, Schaffer DB, Phelps DL, Davis BR, Cooper CJ, for the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative Group. Outcome-based management of retinopathy of prematurity. JAAPOS 1997;1:46-54. Hardy RJ, Davis BR, Palmer, EA, Tung B. Statistical considerations in the early termination of the multicenter trial of cryotherapy for retinopathy of prematurity. Control Clin Trials 1991;12:293-303. Harvey ME, Dobson V, Quinn GE, Tung B, Hardy RJ. Interobserver agreement for grating acuity and letter acuity assessment in 1- to 5.5-year-olds with severe retinopathy of prematurity. Inv Ophthalmol Vis Sci 1999;40:1565-1576. Kivlin JD, Biglan AW, Gordon RA, Dobson V, Hardy RA, Palmer EA, Tung B, Gilbert W, Spencer R, Cheng KP, Buckley E, for the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Cooperative Group. Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Arch Ophthalmol 1996;114:150-154. Msall ME, Phelps DP, Hardy RJ, Dobson V, Quinn GE, Summers CG, Tremont MR, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Educational and social competencies at 8 years in children with threshold ROP in the CRYO-ROP multicenter study. Pediatrics 2004;113:XXX-XXX. Msall ME, Phelps DL, DiGaudio KM, Dobson V, Tung B, McClead RE, Quinn GE, Reynolds JD, Hardy RJ, Palmer EA. Severity of neonatal retinopathy of prematurity (ROP) is predictive of neurodevelopmental functional outcome at age 5.5 years. Pediatrics 2000;106:998-1005. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, Tung B, the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity. Ophthalmology 1991;98:1628-1640.

Palmer EA, Hardy RJ, Mowery R, Davis BR, Tung B, Phelps DL, Schaffer DB, Flynn JT. Operational aspects of early termination of the multicenter trial of cryotherapy for retinopathy of prematurity. Control Clin Trials 1991;12:277-292. Phelps DL, Brown DR, Tung B, Cassady G, McClead RE, Purohit DM, Palmer EA. 28- day survival rates of 6676 neonates with birth weights of 1250 grams or less. Pediatrics 1991;87:7-17. Phelps DL, Phelps CE. Cryotherapy in infants with retinopathy of prematurity: a decision model for treating one or both eyes. JAMA 1989;261:1751-1756. Quinn GE, Dobson V, Siatkowski RM, Hardy RJ, Kivlin J, Palmer EA, Phelps, DL, Repka MX, Summers CG, Tung B, Chan W, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial. Ophthalmology 2001;108:343-347. Quinn GE, Dobson V, Kivlin J, Kaufman LM, Repka MX, Reynolds JD, Gordon RA, Hardy RJ, Tung B, Stone RA, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Prevalence of myopia between 3 months and 5½ years in preterm infants with and without retinopathy of prematurity. Ophthalmology 1998;105:1292-1300. Quinn GE, Dobson V, Hardy RJ, Tung B, Phelps DL, Palmer EA, for the CRYO-ROP Cooperative Group. Visual fields measured with double-arc perimetry in eyes with threshold retinopathy of prematurity (ROP) from the CRYO-ROP trial. Ophthalmology 1996;103:1432-1437. Quinn GE, Dobson V, Barr CC, Davis BR, Palmer EA, Robertson J, Summers CG, Trese MT, Tung B, on behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Visual acuity of eyes after vitrectomy for ROP: Follow-up at 5½ years. Ophthalmology 1996;103:595-600. Quinn GE, Dobson V, Biglan A, Evans J, Plotsky D, Hardy RJ, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Correlation of retinopathy of prematurity in fellow eyes in the CRYO-ROP study. Arch Ophthalmol 1995;113:469-473. Quinn GE, Dobson V, Repka MX, Reynolds J, Kivlin J, Davis B, Buckley E, Flynn JT, Palmer EA. Development of myopia in infants with birth weights less than 1251 grams. Ophthalmology 1992;99:329-340. Quinn GE, Dobson V, Barr CC, Davis BR, Flynn JT, Palmer EA, Robertson J, Trese MT. Visual acuity in infants after vitrectomy for severe retinopathy of prematurity. [Published erratum appears in Ophthalmology 1991;98:1005]. Ophthalmology 1991;98:5-13.

Reynolds JD, Dobson V, Quinn GE, Fielder AR, Palmer EA, Saunders RA, Hardy RJ, Phelps DL, Baker JD, Trese MT, Schaffer DB, Tung B for the CRYO-ROP and LIGHT- ROP Cooperative Groups. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol 2002;120:1470-1476. Reynolds J, Dobson V, Flynn JT, Gilbert WS, Quinn GE, Tung B, Robertson J, Flynn JT for the Cryotherapy for Retinopathy of Prematurity Group. Prediction of visual function in eyes with mild to moderate posterior pole residua of Retinopathy of Prematurity. Arch Ophthalmol 1993;111:1050-1056. Repka MX, Palmer EA, Tung B, on Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Involution of retinopathy of prematurity. Arch Ophthalmol 2000;118:645-649. Repka MX, Summers CG, Palmer EA, Dobson V, Tung B, Davis B, on behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. The incidence of ophthalmological interventions in children with birth weights less than 1251 grams: Results through 5½ years of age. Ophthalmology 1998;105:1621-1627. Repka MX, Hardy RJ, Phelps DL, Summers CG. Surfactant prophylaxis and retinopathy of prematurity. Arch Ophthalmol 1993;111:618-620. Saunders RA, Donahue ML, Christmann LM, Pakalnis AV, Tung B, Hardy RJ, Phelps DL. Racial variation in retinopathy of prematurity. Arch Ophthalmol 1997;115:604-608. Schaffer DB, Palmer EA, Plotsky DF, Metz HS, Flynn JT, Tung B, Hardy RJ, on behalf of The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology 1993;100:230-236. Summers GC, Phelps DL, Tung B, Palmer EA. Ocular cosmesis in retinopathy of prematurity. Arch Ophthalmol 1992;110:1092-1097. Trainor S, White GL, Kivlin JD, Thiese SM, Trunnell E. Follow-up retrospective study of compliance with a standard of care for retinopathy of prematurity in one neonatal intensive care unit. J Ped Ophthalmol Strabismus 1989;26:285-287. Trainor S, White GL, Trunnel E, Kivlin J. Compliance with a standard of care for retinopathy of prematurity in one neonatal intensive care unit. J Ped Ophthalmol Strabismus 1988;25:237-239. Trueb L, Evans J, Hammel A, Bartholomew P, Dobson D. Assessing visual acuity of visually impaired children using the Teller acuity card procedure. Am Orthoptic J 1992;42:149-154.

Watzke RC, Robertson JE, Palmer EA, Wallace PR, Evans MS, Delaney Soldevilla JE. Photographic grading in the retinopathy of prematurity trial. Arch Ophthalmol 1990;108:950-955.